TAK Annual Current Assets
$16.90 B
-$1.09 B-6.07%
31 March 2024
Summary:
As of January 23, 2025, TAK annual total current assets is $16.90 billion, with the most recent change of -$1.09 billion (-6.07%) on March 31, 2024. During the last 3 years, it has fallen by -$7.69 billion (-31.26%). TAK annual current assets is now -37.38% below its all-time high of $26.99 billion, reached on March 31, 2019.TAK Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Quarterly Current Assets
$21.38 B
+$2.07 B+10.74%
01 September 2024
Summary:
As of January 23, 2025, TAK quarterly total current assets is $21.38 billion, with the most recent change of +$2.07 billion (+10.74%) on September 1, 2024. Over the past year, it has increased by +$2.07 billion (+10.74%). TAK quarterly current assets is now -21.31% below its all-time high of $27.18 billion, reached on June 30, 2019.TAK Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.1% | +10.7% |
| 3 y3 years | -31.3% | +18.8% |
| 5 y5 years | -37.4% | -13.1% |
TAK Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.3% | at low | -0.7% | +29.8% |
| 5 y | 5-year | -37.4% | at low | -15.7% | +29.8% |
| alltime | all time | -37.4% | +87.2% | -21.3% | +126.5% |
Takeda Pharmaceutical Company Limited Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $21.38 B(+10.7%) |
| June 2024 | - | $19.31 B(+14.2%) |
| Mar 2024 | $82.92 B(-4.4%) | $16.90 B(-1.8%) |
| Dec 2023 | - | $17.22 B(+4.5%) |
| Sept 2023 | - | $16.48 B(-3.5%) |
| June 2023 | - | $17.07 B(-5.1%) |
| Mar 2023 | $86.76 B(+0.0%) | $18.00 B(-9.1%) |
| Dec 2022 | - | $19.80 B(+4.2%) |
| Sept 2022 | - | $19.01 B(+1.8%) |
| June 2022 | - | $18.66 B(-12.2%) |
| Mar 2022 | $86.72 B(-6.2%) | $21.25 B(-1.3%) |
| Dec 2021 | - | $21.53 B(-1.9%) |
| Sept 2021 | - | $21.94 B(-2.1%) |
| June 2021 | - | $22.40 B(-8.9%) |
| Mar 2021 | $92.46 B(-3.5%) | $24.59 B(-3.1%) |
| Dec 2020 | - | $25.37 B(+3.7%) |
| Sept 2020 | - | $24.46 B(+6.4%) |
| June 2020 | - | $23.00 B(+0.7%) |
| Mar 2020 | $95.78 B(-1.7%) | $22.85 B(-1.3%) |
| Dec 2019 | - | $23.14 B(+5.2%) |
| Sept 2019 | - | $21.99 B(-19.1%) |
| June 2019 | - | $27.18 B(+0.7%) |
| Mar 2019 | $97.40 B(+241.9%) | $26.99 B(+11.6%) |
| Dec 2018 | - | $24.20 B(+148.3%) |
| Sept 2018 | - | $9.75 B(+3.2%) |
| June 2018 | - | $9.44 B(-7.0%) |
| Mar 2018 | $28.49 B(+3.2%) | $10.15 B(-9.6%) |
| Dec 2017 | - | $11.23 B(+3.4%) |
| Sept 2017 | - | $10.86 B(-4.2%) |
| June 2017 | - | $11.34 B(+0.6%) |
| Mar 2017 | $27.60 B(+26.6%) | $11.27 B(-20.8%) |
| Dec 2016 | - | $14.24 B(-2.9%) |
| Sept 2016 | - | $14.66 B(+2.3%) |
| June 2016 | - | $14.33 B(+17.3%) |
| Mar 2016 | $21.80 B | $12.22 B(-5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | $12.86 B(+4.2%) |
| Sept 2015 | - | $12.35 B(+3.0%) |
| June 2015 | - | $11.99 B(-5.3%) |
| Mar 2015 | $23.13 B(-20.0%) | $12.66 B(-11.2%) |
| Dec 2014 | - | $14.26 B(-4.5%) |
| Sept 2014 | - | $14.93 B(-1.1%) |
| June 2014 | - | $15.10 B(-2.4%) |
| Mar 2014 | $28.92 B(-3.5%) | $15.47 B(-9.0%) |
| Dec 2013 | - | $17.00 B(-2.9%) |
| Sept 2013 | - | $17.51 B(+24.7%) |
| June 2013 | - | $14.03 B(+7.3%) |
| Mar 2013 | $29.96 B(-3.1%) | $13.08 B(-15.5%) |
| Dec 2012 | - | $15.48 B(-3.2%) |
| Sept 2012 | - | $15.99 B(+6.0%) |
| June 2012 | - | $15.08 B(+16.9%) |
| Mar 2012 | $30.92 B(+114.3%) | $12.90 B(-19.2%) |
| Dec 2011 | - | $15.97 B(-3.8%) |
| Sept 2011 | - | $16.61 B(-13.2%) |
| June 2011 | - | $19.12 B(+0.3%) |
| Mar 2011 | $14.43 B(+7.9%) | $19.07 B(+4.8%) |
| Dec 2010 | - | $18.19 B(+1.6%) |
| Sept 2010 | - | $17.91 B(+8.1%) |
| June 2010 | - | $16.57 B(-1.5%) |
| Mar 2010 | $13.37 B(+3.0%) | $16.81 B(+4.5%) |
| Dec 2009 | - | $16.09 B(-3.9%) |
| Sept 2009 | - | $16.75 B(+12.4%) |
| Mar 2009 | $12.97 B(+114.1%) | $14.90 B(+3.4%) |
| Dec 2008 | - | $14.41 B |
| Mar 2008 | $6.06 B(-0.0%) | - |
| Mar 2007 | $6.06 B(+6.5%) | - |
| Mar 2006 | $5.69 B(+6.0%) | - |
| Mar 2005 | $5.37 B(-7.6%) | - |
| Mar 2004 | $5.81 B(+32.6%) | - |
| Mar 2003 | $4.38 B(-6.1%) | - |
| Mar 2002 | $4.67 B(-3.4%) | - |
| Mar 2001 | $4.83 B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total current assets?
- What is the all time high annual current assets for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual current assets year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total current assets?
- What is the all time high quarterly current assets for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly current assets year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total current assets?
The current annual current assets of TAK is $16.90 B
What is the all time high annual current assets for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total current assets is $26.99 B
What is Takeda Pharmaceutical Company Limited annual current assets year-on-year change?
Over the past year, TAK annual total current assets has changed by -$1.09 B (-6.07%)
What is Takeda Pharmaceutical Company Limited quarterly total current assets?
The current quarterly current assets of TAK is $21.38 B
What is the all time high quarterly current assets for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total current assets is $27.18 B
What is Takeda Pharmaceutical Company Limited quarterly current assets year-on-year change?
Over the past year, TAK quarterly total current assets has changed by +$2.07 B (+10.74%)